Breast Cancer

33 items

33 items
Breast cancer hormone therapy. LHRH agonists. Tamoxifen. SERDs. Aromatase inhibitors. SERMs. 4
Dr. Marc Lippman. Breast Cancer hormone therapy expert. Biography. 0
Breast cancer treatment. How to select neoadjuvant and adjuvant chemotherapy? 10
When can breast cancer be considered cured? Is cure possible for breast cancer? 5
Hormone therapy for breast cancer. History and advances. 1
Breast cancer hormone therapy. LHRH agonists or bilateral salpingo-oophorectomy (BSO)? 9
Test How to prevent 70% of breast cancers? Tamoxifen. Aromatase inhibitors. 2
Breast cancer hormone therapy. How to choose aromatase inhibitors? 8
Immunotherapy in breast cancer. Immunotherapy is not a magic treatment. 11
Breast cancer hormone therapy. Opposing progestins to prevent or treat breast cancer? 7
How to prevent 70% of breast cancers? Tamoxifen. Aromatase inhibitors. 2
Breast cancer hormone therapy. Tamoxifen vs. Anastrozole? 3
Breast cancer hormone therapy. 5 or 10 years for Aromatase inhibitors? Estrogens promote breast cancer. 6
Breast cancer immunotherapy. Triple-negative breast cancer. Antibody-drug conjugates. 6
Hormonal treatment of breast cancer. Professor Marc E. Lippman.
Seek second opinion from a clinical physician or surgeon. Not from a radiologist. 15
Breast cancer, obesity, and insulin. How metformin helps to delay cancer. 3
Hormone-resistant breast cancer. New endocrine therapy of cancer. 2
How to prevent breast cancer? Chemoprevention with aromatase inhibitors. 10
Early breast cancer, DCIS. How to decide on best therapy? 3
Tumor markers in DCIS breast cancer. Prediction of endocrine treatment and radiotherapy. 2
Ductal Carcinoma In Situ, DCIS. Treatment and prevention. 1
‘You must give the patient a human touch.’ Top breast cancer expert shares wisdom. 10
Metastatic triple-negative breast cancer. Long-term survival. Clinical case. 9
Future in breast cancer therapy. Deescalation of treatment. Cure of metastatic cancer? 8
Immunotherapy side effects in breast cancer patients. 7
Triple-negative breast cancer therapy. Neoadjuvant therapy indications. 5
HER2-positive breast cancer therapy. Tucatinib. Trastuzumab deruxtecan. 4
Hormone-positive, 
HER2-negative breast cancer. Antibody-drug conjugates. 3
Precision medicine in breast cancer therapy. Targeted drugs 
or chemotherapy? 2
Targeted therapy for breast cancer. What are the molecular targets of drugs? 1
Dr. Giuseppe Curigliano. Breast cancer therapy expert. Biography. 0
Locally recurrent breast cancer treatment. 6
Vu récemment

Explore Masterclasses by topic